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Li-Fraumeni Syndrome: a case report from Italy
Sir - F.P. Li et al. have recently reported 24 American
relatives from the National Cancer Institute Cancer Family
Registry with a strikingly high incidence of sarcoma, breast
cancer and other neoplasms in young patients (Li et al.,
1988). Observation of these families has led to the definition
of a cancer family syndrome known as Li-Fraumeni synd-
rome (Li et al., 1988). Twenty-one other families from the
USA and Great Britain have been reported with this synd-
rome (Li, 1988).
We have recently observed, in Italy, a family (Figure 1)
that appears to be an example of this syndrome, charac-
terised by: (1) an autosomal dominant pattern of tumour
incidence in children and young adults (111-4, -11; IV-2; V-2,
-4); (2) a predominance of soft tissue sarcomas, osteosarcoma
and breast cancer, principally infiltrating ductal type (II-3;
III-I 1, -12; IV-2; V-4); (3) an excess of brain tumours,
leukaemia and adrenal cortical cancer (IV-2; V-2); and (4)
occurrence of these types of neoplasms as multiple primary
tumours in young family members (IV-2). No environmental
factors appeared to account for this family cancer aggrega-
tion.
This family was brought to our attention while reviewing
the family history of the proband (V-4), an 11-year-old girl
with chondroblastic osteosarcoma of the left tibia, receiving
therapy at our centre. Fifty per cent of the family members
descended from 1-2 were affected by cancer. Three out of
four tumours in generation IV and V were characterised by
rare histological types: only 25% of osteosarcomas are chon-
droblastic; 10% of adult gliomas are oligodendrogliomas,
with few of these occurring outside the ventricles or frontal
lobes; and less than 10% of primitive neuroectodermal
tumours occur in midline structures. The aggregation of such
rare tumours within a nuclear family supports Li and
Fraumeni's hypothesis that cancer incidence in these families
is not due to chance alone. This is the first report of this
syndrome in a Mediterranean family.
Cancer family syndromes are the object of growing
scientific interest because they offer a unique opportunity to
study the genetic mechanisms behind neoplastic growth. The
chromosomal localisation of the germline mutation responsi-
ble for this syndrome might be identified by genetic linkage
studies in these families. The identification of this syndrome
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Figure I Pedigree. Bo, bone cancer, not otherwise specified
(NOS); Br, breast cancer NOS; Br-D, breast cancer, infiltrating
ductal type; C, colon cancer, 1, intestinal cancer NOS; L, lung
cancer; ODG, oligodendroglioma corpus callosum; OS, chond-
roblastic osteosarcoma; Pa, pancreatic cancer; PNET, primitive
neuroectodermal tumour of thalamus; U, uterine cancer. Hatched
symbols, cancer documented histologically; Filled symbols, cancer
documented by history only. Numbers accompanying each
tumour type represent the age at diagnosis.
in a family offers, in addition, the opportunity to recommend
appropriate diagnostic procedures for the early detection of
breast cancer, and to furnish appropriate genetic counselling.
We suggest the formation of a worldwide registry of such
families, thereby potentiating the collaborative genetic study
on the valuable material obtained from these families.
Yours etc.,
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